Biotech News

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Si-Bone (SIBN)Si-Bone2026-06-25 13:46 ESTEarnings

Fiscal Year 2025 worldwide revenue of $200.8 to $200.9 million, representing growth of ~20% SANTA CLARA, Calif. , Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,

Open original release

Related news

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026

View all latest news

Si-Bone

Si-Bone is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

SIBNSi-Bone2026-06-26 13:25 EST

SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

SIBNSi-Bone2026-06-26 13:25 EST

SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

SIBNSi-Bone2026-06-26 13:25 EST

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SIBNSi-Bone2026-06-26 13:25 EST

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SIBNSi-Bone2026-06-26 13:25 EST

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States